Saturday, September 12, 2026

No Radiation in River Fish Near North Korea, Say Korean Officials

Gyeonggi Province confirmed seafood safety after testing for radioactive contamination due to North Korea's uranium wastewater discharge.

Puppies or Protein? The Cannibalistic Irony of North Korea’s Luxury Pet Store

Kim Jong Un inspects a memorial hall for Russian troops, plans an opening ceremony, and highlights urban development in Pyongyang.

Ripple Sees 1% Price Surge Following CEO’s Meeting With Trump on Digital Asset Strategy

Ripple's CEO urges inclusion of cryptocurrencies in U.S. digital reserves, highlighting cooperation for industry growth.

Tag: Onconic Therapeutics

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Onconic Therapeutics Licenses GERD Drug Zaqubo to Indonesia’s Dexa Medica

Onconic Therapeutics partners with Dexa Medica to commercialize GERD treatment Zaqubo in Indonesia, enhancing its global expansion strategy.

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

Your Guide to Jaqbo: The New GERD Treatment Shaping the Future of Chronic Care

Onconic Therapeutics begins a Phase 3 trial for Jaqbo, aiming to expand GERD treatment options and enhance long-term management strategies.

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.